PRDM12
gene geneOn this page
Also known as PFM9
Summary
PRDM12 (PR/SET domain 12, HGNC:13997) is a protein-coding gene on chromosome 9q34.12, encoding PR domain zinc finger protein 12 (Q9H4Q4). Transcriptional regulator necessary for the development of nociceptive neurons, playing a key role in determining the nociceptive lineage from neural crest cell progenitors.
This gene encodes a transcriptional regulator of sensory neuronal specification that plays a critical role in pain perception. The encoded protein contains an N-terminal PRDI-BF1 and RIZ homology (PR) domain, a SET domain, and three C-terminal C2H2 zinc finger DNA-binding domains. Naturally occurring mutations in this gene are associated with congenital insensitivity to pain (CIP), and hereditary sensory and autonomic neuropathies (HSAN’s) affecting peripheral sensory and autonomic neurons. Deregulation of this gene is associated with solid cancers and hematological malignancies including chronic myeloid leukaemia.
Source: NCBI Gene 59335 — RefSeq curated summary.
At a glance
- Gene–disease (curated): hereditary sensory and autonomic neuropathy (Definitive, GenCC) — +1 more curated relationship
- GWAS associations: 2
- Clinical variants (ClinVar): 293 total — 11 pathogenic, 4 likely-pathogenic
- Phenotypes (HPO): 18
- Druggable target: yes
- MANE Select transcript:
NM_021619
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13997 |
| Approved symbol | PRDM12 |
| Name | PR/SET domain 12 |
| Location | 9q34.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PFM9 |
| Ensembl gene | ENSG00000130711 |
| Ensembl biotype | protein_coding |
| OMIM | 616458 |
| Entrez | 59335 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000253008, ENST00000676323
RefSeq mRNA: 1 — MANE Select: NM_021619
NM_021619
CCDS: CCDS6934
Canonical transcript exons
ENST00000253008 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000868121 | 130664594 | 130664876 |
| ENSE00000868122 | 130666608 | 130666798 |
| ENSE00000868123 | 130668158 | 130668313 |
| ENSE00000868124 | 130678529 | 130678640 |
| ENSE00001052791 | 130681248 | 130682983 |
Expression profiles
Bgee: expression breadth broad, 41 present calls, max score 88.71.
Top tissues by expression
215 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| type B pancreatic cell | CL:0000169 | 88.71 | gold quality |
| buccal mucosa cell | CL:0002336 | 86.87 | gold quality |
| olfactory bulb | UBERON:0002264 | 85.10 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 80.28 | silver quality |
| cervix squamous epithelium | UBERON:0006922 | 78.72 | gold quality |
| diaphragm | UBERON:0001103 | 77.20 | gold quality |
| vena cava | UBERON:0004087 | 76.82 | silver quality |
| vastus lateralis | UBERON:0001379 | 76.48 | gold quality |
| thymus | UBERON:0002370 | 76.22 | silver quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 75.92 | gold quality |
| trachea | UBERON:0003126 | 75.16 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 74.95 | silver quality |
| triceps brachii | UBERON:0001509 | 74.71 | gold quality |
| cerebellar vermis | UBERON:0004720 | 74.67 | gold quality |
| cardia of stomach | UBERON:0001162 | 74.34 | gold quality |
| pericardium | UBERON:0002407 | 74.34 | silver quality |
| biceps brachii | UBERON:0001507 | 74.15 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 74.05 | gold quality |
| pons | UBERON:0000988 | 73.98 | gold quality |
| pylorus | UBERON:0001166 | 73.93 | gold quality |
| superior surface of tongue | UBERON:0007371 | 73.83 | gold quality |
| penis | UBERON:0000989 | 73.13 | silver quality |
| male germ cell | CL:0000015 | 72.86 | gold quality |
| renal medulla | UBERON:0000362 | 72.81 | gold quality |
| globus pallidus | UBERON:0001875 | 72.36 | silver quality |
| cervix epithelium | UBERON:0004801 | 72.04 | gold quality |
| medial globus pallidus | UBERON:0002477 | 71.93 | silver quality |
| gluteal muscle | UBERON:0002000 | 71.83 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 71.80 | gold quality |
| sperm | CL:0000019 | 71.73 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.48 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
50 targeting PRDM12, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-6856-5P | 100.00 | 65.47 | 1298 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-381-3P | 99.93 | 71.87 | 2854 |
| HSA-MIR-300 | 99.92 | 71.76 | 2856 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-5003-3P | 99.85 | 69.29 | 2517 |
| HSA-MIR-205-5P | 99.81 | 70.05 | 1557 |
| HSA-MIR-577 | 99.78 | 69.13 | 2479 |
| HSA-MIR-1299 | 99.77 | 71.24 | 2389 |
| HSA-MIR-4699-3P | 99.71 | 70.15 | 3142 |
| HSA-MIR-1284 | 99.67 | 73.56 | 1353 |
| HSA-MIR-6751-5P | 99.56 | 64.99 | 1145 |
| HSA-MIR-3609 | 99.52 | 69.89 | 2587 |
| HSA-MIR-548AH-5P | 99.52 | 69.73 | 2626 |
| HSA-MIR-582-5P | 99.47 | 70.79 | 2635 |
| HSA-MIR-889-3P | 99.40 | 69.76 | 2103 |
| HSA-MIR-3182 | 99.40 | 68.15 | 2454 |
| HSA-MIR-3176 | 99.25 | 64.35 | 954 |
| HSA-MIR-3922-3P | 99.25 | 64.96 | 1136 |
| HSA-MIR-6803-5P | 99.19 | 63.90 | 1026 |
Literature-anchored findings (GeneRIF, showing 7)
- Down-regulation of PRDM12 is associated with the pathogenesis of chronic myeloid leukaemia with derivative chromosome 9 deletion (PMID:14523459)
- PRDM12 and its functional fly homolog Hamlet are evolutionary conserved master regulators of sensory neuronal specification and play a critical role in pain perception (PMID:25891934)
- Prdm12 is a key factor in the orchestration of sensory neurogenesis. (PMID:26005867)
- The natural history of the PRDM12-CIP disorder. (PMID:26975306)
- Study in five further children, from four families, with facial lesions typical of midface toddler excoriation syndrome (MiTES) found autosomal recessive mutations in PRDM12 in four of five patients and extended the phenotypic spectrum of PRDM12 mutations, which usually cause hereditary sensory and autonomic neuropathy type VIII, characterized by mutilating self-inflicted wounds of the extremities, lips and tongue. (PMID:29949203)
- PRDM12 in Health and Diseases. (PMID:34769459)
- Ocular manifestations among patients with congenital insensitivity to pain due to variants in PRDM12 and SCN9A genes. (PMID:36111846)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | prdm12b | ENSDARG00000007430 |
| mus_musculus | Prdm12 | ENSMUSG00000079466 |
| rattus_norvegicus | Prdm12 | ENSRNOG00000009218 |
Paralogs (28): ZNF280C (ENSG00000056277), ZBTB25 (ENSG00000089775), PRDM13 (ENSG00000112238), BCL6 (ENSG00000113916), FEZF1 (ENSG00000128610), ZBTB46 (ENSG00000130584), ZNF280D (ENSG00000137871), NACC2 (ENSG00000148411), FEZF2 (ENSG00000153266), ZBTB7B (ENSG00000160685), NACC1 (ENSG00000160877), BCL6B (ENSG00000161940), GFI1 (ENSG00000162676), GFI1B (ENSG00000165702), ZBTB49 (ENSG00000168826), ZNF280A (ENSG00000169548), ZNF581 (ENSG00000171425), ZNF524 (ENSG00000171443), ZBTB26 (ENSG00000171448), ZBTB21 (ENSG00000173276), ZNF683 (ENSG00000176083), ZBTB33 (ENSG00000177485), ZBTB3 (ENSG00000185670), ZBTB6 (ENSG00000186130), ZBTB14 (ENSG00000198081), ZBTB12 (ENSG00000204366), ZNF580 (ENSG00000213015), ZNF280B (ENSG00000275004)
Protein
Protein identifiers
PR domain zinc finger protein 12 — Q9H4Q4 (reviewed: Q9H4Q4)
Alternative names: PR domain-containing protein 12
All UniProt accessions (2): Q9H4Q4, A0A6Q8PH01
UniProt curated annotations — full annotation on UniProt →
Function. Transcriptional regulator necessary for the development of nociceptive neurons, playing a key role in determining the nociceptive lineage from neural crest cell progenitors. Initiates neurogenesis and activates downstream pro-neuronal transcription factors, such as NEUROD1, BRN3A, and ISL1, specifically within nociceptive neurons, while repressing non-nociceptor cell fates. Essential for the proper function of nociceptors in adults, influencing both their excitability and their gene expression, thereby impacting how these neurons respond to various pain stimuli.
Subunit / interactions. Interacts with EHMT2.
Subcellular location. Nucleus.
Tissue specificity. Not found in adult tissues except in dorsal root ganglia.
Disease relevance. Neuropathy, hereditary sensory and autonomic, 8 (HSAN8) [MIM:616488] A form of hereditary sensory and autonomic neuropathy, a genetically and clinically heterogeneous group of disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and by sensory and/or autonomic abnormalities. HSAN8 patients manifest congenital insensitivity to pain resulting in ulceration to the fingers, tongue, lips, and other distal appendages. Some patients may also have decreased sweating and tear production. The disease is caused by variants affecting the gene represented in this entry.
Polymorphism. The poly-alanine tract is polymorphic in the general population and contains a maximum of 14 alanines.
Similarity. Belongs to the class V-like SAM-binding methyltransferase superfamily.
RefSeq proteins (1): NP_067632* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001214 | SET_dom | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR017126 | Znf_PRDM12 | Family |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR044406 | PRDM12_PR/SET | Domain |
| IPR046341 | SET_dom_sf | Homologous_superfamily |
| IPR050331 | Zinc_finger_PRDM4/PRDM1/PRDM14 | Family |
Pfam: PF00096, PF21549
UniProt features (26 total): strand 11, sequence variant 7, zinc finger region 3, chain 1, domain 1, helix 1, turn 1, region of interest 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 3EP0 | X-RAY DIFFRACTION | 2.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H4Q4-F1 | 64.81 | 0.12 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 147 (showing top):
CREL_01, BENPORATH_ES_WITH_H3K27ME3, GOBP_SENSORY_PERCEPTION_OF_TEMPERATURE_STIMULUS, GOBP_NEUROGENESIS, EFC_Q6, NFKB_Q6, GOBP_SENSORY_PERCEPTION_OF_PAIN, CDP_01, GOBP_DETECTION_OF_TEMPERATURE_STIMULUS, ATF1_Q6, GOBP_NEURON_FATE_SPECIFICATION, TGANTCA_AP1_C, GOBP_RESPONSE_TO_ABIOTIC_STIMULUS, NKX22_01, TATA_C
GO Biological Process (10): negative regulation of transcription by RNA polymerase II (GO:0000122), protein methylation (GO:0006479), regulation of gene expression (GO:0010468), sensory perception of pain (GO:0019233), neurogenesis (GO:0022008), neuron projection development (GO:0031175), neuron fate specification (GO:0048665), detection of temperature stimulus involved in sensory perception of pain (GO:0050965), methylation (GO:0032259), positive regulation of transcription by RNA polymerase II (GO:0045944)
GO Molecular Function (11): DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228), DNA binding (GO:0003677), zinc ion binding (GO:0008270), histone chaperone activity (GO:0140713), histone methyltransferase binding (GO:1990226), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), protein binding (GO:0005515), methyltransferase activity (GO:0008168), transferase activity (GO:0016740), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), nucleoplasm (GO:0005654)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of transcription by RNA polymerase II | 3 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 3 |
| transcription by RNA polymerase II | 2 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 2 |
| negative regulation of DNA-templated transcription | 1 |
| protein alkylation | 1 |
| macromolecule methylation | 1 |
| gene expression | 1 |
| regulation of macromolecule biosynthetic process | 1 |
| sensory perception | 1 |
| nervous system development | 1 |
| cell differentiation | 1 |
| neuron development | 1 |
| plasma membrane bounded cell projection organization | 1 |
| cell fate specification | 1 |
| neuron fate commitment | 1 |
| sensory perception of pain | 1 |
| detection of temperature stimulus involved in sensory perception | 1 |
| metabolic process | 1 |
| positive regulation of DNA-templated transcription | 1 |
| negative regulation of transcription by RNA polymerase II | 1 |
| DNA-binding transcription repressor activity | 1 |
| DNA-binding transcription activator activity | 1 |
| positive regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| transition metal ion binding | 1 |
| histone binding | 1 |
| protein carrier activity | 1 |
| enzyme binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| binding | 1 |
| transferase activity, transferring one-carbon groups | 1 |
| catalytic activity | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
570 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PRDM12 | EHMT2 | Q96KQ7 | 624 |
| PRDM12 | DRGX | A6NNA5 | 575 |
| PRDM12 | NEUROG1 | Q92886 | 557 |
| PRDM12 | PRDM11 | Q9NQV5 | 542 |
| PRDM12 | SCN11A | Q9UI33 | 505 |
| PRDM12 | SCN9A | Q15858 | 476 |
| PRDM12 | PHOX2B | Q99453 | 455 |
| PRDM12 | ASIC3 | Q9UHC3 | 448 |
| PRDM12 | TRPV1 | Q8NER1 | 445 |
| PRDM12 | NEUROD2 | Q15784 | 437 |
| PRDM12 | DBX1 | A6NMT0 | 424 |
| PRDM12 | GPR101 | Q96P66 | 413 |
| PRDM12 | OR11L1 | Q8NGX0 | 411 |
| PRDM12 | POU4F1 | Q01851 | 399 |
| PRDM12 | EN1 | Q05925 | 399 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PRDM12 | SERPINB8 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (3): PRDM12 (Affinity Capture-MS), SERPINB8 (Affinity Capture-MS), RUNX1T1 (Affinity Capture-MS)
ESM2 similar proteins: A0A140LI67, A0JN76, A1L2U9, A2A5N8, A2AJ77, A6QPM3, B1WAZ8, B8A5Y1, D3ZWK4, E9Q3T6, E9Q8T2, O15060, O88866, O94966, P0C2N6, P57058, Q05516, Q0IH98, Q0IJ29, Q3B725, Q3TES0, Q3UZD5, Q4R739, Q60760, Q68UT7, Q6NZK8, Q6P2A1, Q6P4K6, Q6Q783, Q6S5L9, Q6YND2, Q76M68, Q7ZWZ4, Q80X44, Q8BXX2, Q8N680, Q8NE63, Q96CK0, Q99592, Q9GZV8
Diamond homologs: A0A163UT06, A2A935, A2AGX3, A2AJ77, B8A5Y1, E9Q3T6, O75626, P0C6Y7, P14404, Q03112, Q13029, Q3UZD5, Q60636, Q63755, Q6P2A1, Q8BZ97, Q96EQ9, Q9GZV8, Q9H4Q4, Q9HAZ2, Q9NQV5, Q9NQV7, Q9NQV8, Q9NQW5, A6QPM3, Q9CXE0, Q9NQX0, Q9NQX1, E9PZZ1, Q9H4Q3, A2BID7, Q6DCW1, Q9VH70, B4F6U4, E9Q8T2, I7HJS4, P57071, Q3UTQ7, Q5R5M1, Q5RAX9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
293 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 11 |
| Likely pathogenic | 4 |
| Uncertain significance | 139 |
| Likely benign | 102 |
| Benign | 21 |
Top pathogenic / likely-pathogenic (15)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1072417 | NM_021619.3(PRDM12):c.224-1G>A | Pathogenic |
| 1323492 | NM_021619.3(PRDM12):c.131_138del (p.Val44fs) | Pathogenic |
| 1332705 | NM_021619.3(PRDM12):c.785T>G (p.Met262Arg) | Pathogenic |
| 1745663 | NM_021619.3(PRDM12):c.514G>T (p.Glu172Ter) | Pathogenic |
| 253118 | NM_021619.3(PRDM12):c.1041CGC[(15_?)] | Pathogenic |
| 253120 | NM_021619.3(PRDM12):c.91G>T (p.Asp31Tyr) | Pathogenic |
| 253121 | NM_021619.3(PRDM12):c.516G>C (p.Glu172Asp) | Pathogenic |
| 253122 | NM_021619.3(PRDM12):c.866A>T (p.His289Leu) | Pathogenic |
| 2706647 | NM_021619.3(PRDM12):c.578dup (p.Pro194fs) | Pathogenic |
| 59908 | GRCh38/hg38 9q34.11-34.3(chr9:129068560-136495351)x3 | Pathogenic |
| 916004 | GRCh37/hg19 9q34.12(chr9:133553916-133554028) | Pathogenic |
| 3773873 | NM_021619.3(PRDM12):c.455C>A (p.Ala152Asp) | Likely pathogenic |
| 430206 | NM_021619.3(PRDM12):c.811T>G (p.Phe271Val) | Likely pathogenic |
| 451909 | NM_021619.3(PRDM12):c.600_606delinsCA (p.Trp201fs) | Likely pathogenic |
| 848182 | NM_021619.3(PRDM12):c.1041CGC[18] (p.Ala354_Ala359dup) | Likely pathogenic |
SpliceAI
772 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:130666794:GGGAG:G | donor_gain | 1.0000 |
| 9:130666795:GGAGG:G | donor_gain | 1.0000 |
| 9:130666796:G:T | donor_gain | 1.0000 |
| 9:130666797:AGG:A | donor_loss | 1.0000 |
| 9:130666799:G:C | donor_loss | 1.0000 |
| 9:130668153:CCCA:C | acceptor_loss | 1.0000 |
| 9:130668156:A:AG | acceptor_gain | 1.0000 |
| 9:130668156:A:C | acceptor_loss | 1.0000 |
| 9:130668157:G:GG | acceptor_gain | 1.0000 |
| 9:130668157:GGT:G | acceptor_gain | 1.0000 |
| 9:130668269:G:GT | donor_gain | 1.0000 |
| 9:130668305:GCCAT:G | donor_gain | 1.0000 |
| 9:130668314:G:GG | donor_loss | 1.0000 |
| 9:130668315:T:A | donor_loss | 1.0000 |
| 9:130678526:CAGAT:C | acceptor_loss | 1.0000 |
| 9:130678527:A:AC | acceptor_loss | 1.0000 |
| 9:130678527:A:AG | acceptor_gain | 1.0000 |
| 9:130678527:AGAT:A | acceptor_gain | 1.0000 |
| 9:130678528:G:GT | acceptor_gain | 1.0000 |
| 9:130678528:GA:G | acceptor_gain | 1.0000 |
| 9:130678528:GAT:G | acceptor_gain | 1.0000 |
| 9:130678528:GATG:G | acceptor_gain | 1.0000 |
| 9:130678528:GATGA:G | acceptor_gain | 1.0000 |
| 9:130678636:GCATG:G | donor_gain | 1.0000 |
| 9:130678638:ATG:A | donor_gain | 1.0000 |
| 9:130678639:TG:T | donor_gain | 1.0000 |
| 9:130678640:GG:G | donor_gain | 1.0000 |
| 9:130678640:GGT:G | donor_loss | 1.0000 |
| 9:130678641:G:GC | donor_loss | 1.0000 |
| 9:130678641:G:GG | donor_gain | 1.0000 |
AlphaMissense
2410 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:130681298:T:C | C245R | 1.000 |
| 9:130681307:T:C | C248R | 1.000 |
| 9:130681308:G:A | C248Y | 1.000 |
| 9:130681309:C:G | C248W | 1.000 |
| 9:130681319:T:C | F252L | 1.000 |
| 9:130681321:C:A | F252L | 1.000 |
| 9:130681321:C:G | F252L | 1.000 |
| 9:130681403:T:C | F280L | 1.000 |
| 9:130681405:C:A | F280L | 1.000 |
| 9:130681405:C:G | F280L | 1.000 |
| 9:130666793:T:A | W137R | 0.999 |
| 9:130666793:T:C | W137R | 0.999 |
| 9:130668267:T:C | L175P | 0.999 |
| 9:130668299:T:G | Y186D | 0.999 |
| 9:130678551:T:C | L198P | 0.999 |
| 9:130681298:T:A | C245S | 0.999 |
| 9:130681299:G:C | C245S | 0.999 |
| 9:130681300:C:G | C245W | 0.999 |
| 9:130681307:T:A | C248S | 0.999 |
| 9:130681308:G:C | C248S | 0.999 |
| 9:130681320:T:C | F252S | 0.999 |
| 9:130681338:T:C | L258P | 0.999 |
| 9:130681346:C:A | H261N | 0.999 |
| 9:130681346:C:G | H261D | 0.999 |
| 9:130681348:C:A | H261Q | 0.999 |
| 9:130681348:C:G | H261Q | 0.999 |
| 9:130681353:G:C | R263P | 0.999 |
| 9:130681382:T:C | C273R | 0.999 |
| 9:130681384:C:G | C273W | 0.999 |
| 9:130681404:T:C | F280S | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000316444 (9:130678275 T>C), RS1000329734 (9:130681788 G>C,T), RS1000524777 (9:130664059 G>A), RS1000537767 (9:130667728 G>A,T), RS1000675967 (9:130664004 C>A,G,T), RS1000862735 (9:130677372 G>A,T), RS1001020599 (9:130672258 A>G), RS1001121965 (9:130677591 G>T), RS1001126577 (9:130662743 G>T), RS1001190577 (9:130663164 G>A), RS1001193993 (9:130678328 G>A,C,T), RS1001417824 (9:130668670 C>A,T), RS1001429154 (9:130673298 G>A), RS1001712762 (9:130663176 AG>A), RS1001762614 (9:130673503 CTT>C,CT,CTTT)
Disease associations
OMIM: gene MIM:616458 | disease phenotypes: MIM:616488, MIM:162400
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| hereditary sensory and autonomic neuropathy | Definitive | Autosomal recessive |
| congenital insensitivity to pain-hypohidrosis syndrome | Definitive | Autosomal recessive |
Mondo (2): congenital insensitivity to pain-hypohidrosis syndrome (MONDO:0014662), hereditary sensory and autonomic neuropathy (MONDO:0015364)
Orphanet (2): Hereditary sensory and autonomic neuropathy type 8 (Orphanet:478664), Hereditary sensory and autonomic neuropathy (Orphanet:140471)
HPO phenotypes
18 total (18 of 18 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000407 | Sensorineural hearing impairment |
| HP:0000559 | Corneal scarring |
| HP:0000633 | Decreased lacrimation |
| HP:0000966 | Hypohidrosis |
| HP:0001249 | Intellectual disability |
| HP:0001265 | Hyporeflexia |
| HP:0001581 | Recurrent skin infections |
| HP:0002495 | Impaired vibratory sensation |
| HP:0002579 | Gastrointestinal dysmotility |
| HP:0003593 | Infantile onset |
| HP:0004409 | Hyposmia |
| HP:0007021 | Pain insensitivity |
| HP:0010829 | Impaired temperature sensation |
| HP:0010831 | Impaired proprioception |
| HP:0011463 | Childhood onset |
| HP:0012804 | Corneal ulceration |
| HP:0033748 | Hypoesthesia |
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002304_7 | Fractional exhaled nitric oxide (childhood) | 5.000000e-06 |
| GCST008839_9 | Height | 8.000000e-28 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005536 | nitric oxide exhalation measurement |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| D009477 | Hereditary Sensory and Autonomic Neuropathies | C10.500.250; C10.574.500.493; C10.668.829.800.175; C16.131.666.310; C16.320.400.415 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL5214854 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression, decreases methylation, increases methylation, increases mutagenesis | 3 |
| Aflatoxin B1 | increases expression, increases methylation | 2 |
| hydroxyhydroquinone | decreases expression, decreases reaction | 1 |
| arsenite | increases methylation | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| 4-aminobenzhydrazide | decreases reaction, decreases expression | 1 |
| abrine | decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Decitabine | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Diethylhexyl Phthalate | increases expression | 1 |
| Phthalic Acids | increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Progesterone | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | decreases expression, increases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
| S-Nitrosoglutathione | increases expression | 1 |
| Particulate Matter | increases expression, increases abundance | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5214661 | Binding | Selectivity interaction (Methyltransferase panel (DSF assay)) EUB0000234b PRDM12 | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_HC90 | HEK293 eGFP-PRDM12 | Transformed cell line | Female |
Clinical trials (associated diseases)
4 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT02624310 | PHASE2 | WITHDRAWN | A Study of Norepinephrine in Patients With Congenital Insensitivity to Pain and Anhidrosis |
| NCT02696746 | Not specified | UNKNOWN | Painful Channelopathies Study |
| NCT03920774 | Not specified | RECRUITING | The Natural History of Familial Dysautonomia |
| NCT05527379 | Not specified | COMPLETED | Interest of Virtual Reality to Reduce Patient Anxiety During the Placement of a Percutaneous Implantable Port Catheter |
Related Atlas pages
- Associated diseases: hereditary sensory and autonomic neuropathy, congenital insensitivity to pain-hypohidrosis syndrome
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): congenital insensitivity to pain-hypohidrosis syndrome, hereditary sensory and autonomic neuropathy